Report Cover

United States Gene Therapy Market Report & Forecast 2021-2027


United States Gene Therapy Market, By Type, 2016-2021, 2022-2027 ($ Millions)
United States Gene Therapy Market Segment Percentages, By Type, 2020 (%)
    Viral Gene Therapy
    Non-Viral Gene Therapy

United States Gene Therapy Market, By Application, 2016-2021, 2022-2027 ($ Millions)
United States Gene Therapy Market Segment Percentages, By Application, 2020 (%)
    Neurological Diseases
    Cancer
    Other

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Therapy revenues in United States market, 2016-2021 (Estimated), ($ millions)
Key companies Gene Therapy revenues share in United States market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Biogen
    Novartis
    Gilead Sciences
    Sarepta Therapeutics
    Alnylam Pharmaceuticals
    Amgen
    Spark Therapeutics
    Akcea Therapeutics
    bluebird bio
    Sunway Biotech
    SIBIONO
    AnGes
    Orchard Therapeutics
    Human Stem Cells Institute
1 Introduction to Research & Analysis Reports
    1.1 Gene Therapy Market Definition
    1.2 Market Segments
        1.2.1 Segment by Type
        1.2.2 Segment by Application
    1.3 United States Gene Therapy Market Overview
    1.4 Methodology & Sources of Information
        1.4.1 Research Methodology
        1.4.2 Research Process
        1.4.3 Base Year

2 United States Gene Therapy Overall Market Size
    2.1 United States Gene Therapy Market Size: 2021 VS 2027
    2.2 United States Gene Therapy Revenue, Prospects & Forecasts: 2016-2027
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints

3 Company Landscape
    3.1 Top Gene Therapy Players in United States Market
    3.2 Top United States Gene Therapy Companies Ranked by Revenue
    3.3 United States Gene Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Gene Therapy Companies in United States Market, by Revenue in 2020
    3.5 Companies Gene Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Gene Therapy Players in United States Market
        3.6.1 List of Tier 1 Gene Therapy Companies in United States
        3.6.2 List of Tier 2 and Tier 3 Gene Therapy Companies in United States

4 Sights by Type
    4.1 Overview
        4.1.1 By Type - United States Gene Therapy Market Size Markets, 2021 & 2027
        4.1.2 Viral Gene Therapy
        4.1.3 Non-Viral Gene Therapy
    4.2 By Type - United States Gene Therapy Revenue & Forecasts
        4.2.1 By Type - United States Gene Therapy Revenue, 2016-2021
        4.2.2 By Type - United States Gene Therapy Revenue, 2022-2027
        4.2.3 By Type - United States Gene Therapy Revenue Market Share, 2016-2027

5 Sights by Application
    5.1 Overview
        5.1.1 By Application - United States Gene Therapy Market Size, 2021 & 2027
        5.1.2 Neurological Diseases
        5.1.3 Cancer
        5.1.4 Other
    5.2 By Application - United States Gene Therapy Revenue & Forecasts
        5.2.1 By Application - United States Gene Therapy Revenue, 2016-2021
        5.2.2 By Application - United States Gene Therapy Revenue, 2022-2027
        5.2.3 By Application - United States Gene Therapy Revenue Market Share, 2016-2027

6 Gene Therapy Companies Profiles
    6.1 Biogen
        6.1.1 Biogen Company Details
        6.1.2 Biogen Business Overview
        6.1.3 Biogen Gene Therapy Introduction
        6.1.4 Biogen Gene Therapy Revenue in United States Market (2016-2021)
        6.1.5 Biogen Recent Developments
    6.2 Novartis
        6.2.1 Novartis Company Details
        6.2.2 Novartis Business Overview
        6.2.3 Novartis Gene Therapy Introduction
        6.2.4 Novartis Gene Therapy Revenue in United States Market (2016-2021)
        6.2.5 Novartis Recent Developments
    6.3 Gilead Sciences
        6.3.1 Gilead Sciences Company Details
        6.3.2 Gilead Sciences Business Overview
        6.3.3 Gilead Sciences Gene Therapy Introduction
        6.3.4 Gilead Sciences Gene Therapy Revenue in United States Market (2016-2021)
        6.3.5 Gilead Sciences Recent Developments
    6.4 Sarepta Therapeutics
        6.4.1 Sarepta Therapeutics Company Details
        6.4.2 Sarepta Therapeutics Business Overview
        6.4.3 Sarepta Therapeutics Gene Therapy Introduction
        6.4.4 Sarepta Therapeutics Gene Therapy Revenue in United States Market (2016-2021)
        6.4.5 Sarepta Therapeutics Recent Developments
    6.5 Alnylam Pharmaceuticals
        6.5.1 Alnylam Pharmaceuticals Company Details
        6.5.2 Alnylam Pharmaceuticals Business Overview
        6.5.3 Alnylam Pharmaceuticals Gene Therapy Introduction
        6.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue in United States Market (2016-2021)
        6.5.5 Alnylam Pharmaceuticals Recent Developments
    6.6 Amgen
        6.6.1 Amgen Company Details
        6.6.2 Amgen Business Overview
        6.6.3 Amgen Gene Therapy Introduction
        6.6.4 Amgen Gene Therapy Revenue in United States Market (2016-2021)
        6.6.5 Amgen Recent Developments
    6.7 Spark Therapeutics
        6.7.1 Spark Therapeutics Company Details
        6.7.2 Spark Therapeutics Business Overview
        6.7.3 Spark Therapeutics Gene Therapy Introduction
        6.7.4 Spark Therapeutics Gene Therapy Revenue in United States Market (2016-2021)
        6.7.5 Spark Therapeutics Recent Developments
    6.8 Akcea Therapeutics
        6.8.1 Akcea Therapeutics Company Details
        6.8.2 Akcea Therapeutics Business Overview
        6.8.3 Akcea Therapeutics Gene Therapy Introduction
        6.8.4 Akcea Therapeutics Gene Therapy Revenue in United States Market (2016-2021)
        6.8.5 Akcea Therapeutics Recent Developments
    6.9 bluebird bio
        6.9.1 bluebird bio Company Details
        6.9.2 bluebird bio Business Overview
        6.9.3 bluebird bio Gene Therapy Introduction
        6.9.4 bluebird bio Gene Therapy Revenue in United States Market (2016-2021)
        6.9.5 bluebird bio Recent Developments
    6.10 Sunway Biotech
        6.10.1 Sunway Biotech Company Details
        6.10.2 Sunway Biotech Business Overview
        6.10.3 Sunway Biotech Gene Therapy Introduction
        6.10.4 Sunway Biotech Gene Therapy Revenue in United States Market (2016-2021)
        6.10.5 Sunway Biotech Recent Developments
    6.11 SIBIONO
        6.11.1 SIBIONO Company Details
        6.11.2 SIBIONO Business Overview
        6.11.3 SIBIONO Gene Therapy Introduction
        6.11.4 SIBIONO Gene Therapy Revenue in United States Market (2016-2021)
        6.11.5 SIBIONO Recent Developments
    6.12 AnGes
        6.12.1 AnGes Company Details
        6.12.2 AnGes Business Overview
        6.12.3 AnGes Gene Therapy Introduction
        6.12.4 AnGes Gene Therapy Revenue in United States Market (2016-2021)
        6.12.5 AnGes Recent Developments
    6.13 Orchard Therapeutics
        6.13.1 Orchard Therapeutics Company Details
        6.13.2 Orchard Therapeutics Business Overview
        6.13.3 Orchard Therapeutics Gene Therapy Introduction
        6.13.4 Orchard Therapeutics Gene Therapy Revenue in United States Market (2016-2021)
        6.13.5 Orchard Therapeutics Recent Developments
    6.14 Human Stem Cells Institute
        6.14.1 Human Stem Cells Institute Company Details
        6.14.2 Human Stem Cells Institute Business Overview
        6.14.3 Human Stem Cells Institute Gene Therapy Introduction
        6.14.4 Human Stem Cells Institute Gene Therapy Revenue in United States Market (2016-2021)
        6.14.5 Human Stem Cells Institute Recent Developments

7 Conclusion
8 Appendix
    8.1 Note
    8.2 Examples of Clients
    8.3 Author Details
    8.4 Disclaimer

List of Tables Table 1. Gene Therapy Market Opportunities & Trends in United States Market Table 2. Gene Therapy Market Drivers in United States Market Table 3. Gene Therapy Market Restraints in United States Market Table 4. Key Players of Gene Therapy in United States Market Table 5. Top Gene Therapy Players in United States Market, Ranking by Revenue (2019) Table 6. United States Gene Therapy Revenue by Companies, (US$, Mn), 2016-2021 Table 7. United States Gene Therapy Revenue Share by Companies, 2016-2021 Table 8. Companies Gene Therapy Product Type Table 9. List of Tier 1 Gene Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share Table 10. List of Tier 2 and Tier 3 Gene Therapy Companies, Revenue (US$, Mn) in 2020 and Market Share Table 11. By Type - United States Gene Therapy Revenue, (US$, Mn), 2021 & 2027 Table 12. By Type - United States Gene Therapy Revenue (US$, Mn), 2016-2021 Table 13. By Type - United States Gene Therapy Revenue (US$, Mn), 2022-2027 Table 14. By Application - United States Gene Therapy Revenue, (US$, Mn), 2021 VS 2027 Table 15. By Application - United States Gene Therapy Revenue (US$, Mn), 2016-2021 Table 16. By Application - United States Gene Therapy Revenue (US$, Mn), 2022-2027 Table 17. Biogen Company Details Table 18. Biogen Business Overview Table 19. Biogen Gene Therapy Product Table 20. Biogen Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 21. Biogen Recent Developments Table 22. Novartis Company Details Table 23. Novartis Business Overview Table 24. Novartis Gene Therapy Product Table 25. Novartis Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 26. Novartis Recent Developments Table 27. Gilead Sciences Company Details Table 28. Gilead Sciences Business Overview Table 29. Gilead Sciences Gene Therapy Product Table 30. Gilead Sciences Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 31. Gilead Sciences Recent Developments Table 32. Sarepta Therapeutics Company Details Table 33. Sarepta Therapeutics Business Overview Table 34. Sarepta Therapeutics Gene Therapy Product Table 35. Sarepta Therapeutics Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 36. Sarepta Therapeutics Recent Developments Table 37. Alnylam Pharmaceuticals Company Details Table 38. Alnylam Pharmaceuticals Business Overview Table 39. Alnylam Pharmaceuticals Gene Therapy Product Table 40. Alnylam Pharmaceuticals Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 41. Alnylam Pharmaceuticals Recent Developments Table 42. Amgen Company Details Table 43. Amgen Business Overview Table 44. Amgen Gene Therapy Product Table 45. Amgen Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 46. Amgen Recent Developments Table 47. Spark Therapeutics Company Details Table 48. Spark Therapeutics Business Overview Table 49. Spark Therapeutics Gene Therapy Product Table 50. Spark Therapeutics Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 51. Spark Therapeutics Recent Developments Table 52. Akcea Therapeutics Company Details Table 53. Akcea Therapeutics Business Overview Table 54. Akcea Therapeutics Gene Therapy Product Table 55. Akcea Therapeutics Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 56. Akcea Therapeutics Recent Developments Table 57. bluebird bio Company Details Table 58. bluebird bio Business Overview Table 59. bluebird bio Gene Therapy Product Table 60. bluebird bio Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 61. bluebird bio Recent Developments Table 62. Sunway Biotech Company Details Table 63. Sunway Biotech Business Overview Table 64. Sunway Biotech Gene Therapy Product Table 65. Sunway Biotech Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 66. Sunway Biotech Recent Developments Table 67. SIBIONO Company Details Table 68. SIBIONO Business Overview Table 69. SIBIONO Gene Therapy Product Table 70. SIBIONO Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 71. SIBIONO Recent Developments Table 72. AnGes Company Details Table 73. AnGes Business Overview Table 74. AnGes Gene Therapy Product Table 75. AnGes Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 76. AnGes Recent Developments Table 77. Orchard Therapeutics Company Details Table 78. Orchard Therapeutics Business Overview Table 79. Orchard Therapeutics Gene Therapy Product Table 80. Orchard Therapeutics Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 81. Orchard Therapeutics Recent Developments Table 82. Human Stem Cells Institute Company Details Table 83. Human Stem Cells Institute Business Overview Table 84. Human Stem Cells Institute Gene Therapy Product Table 85. Human Stem Cells Institute Gene Therapy Revenue in United States Market (2016-2021) & (US$ Million) Table 86. Human Stem Cells Institute Recent Developments List of Figures Figure 1. Gene Therapy Segment by Type Figure 2. Gene Therapy Segment by Application Figure 3. United States Gene Therapy Market Overview: 2020 Figure 4. United States Gene Therapy Market Size: 2021 VS 2027 (US$, Mn) Figure 5. United States Gene Therapy Revenue, 2016-2027 (US$, Mn) Figure 6. The Top 3 and 5 Players Market Share by Gene Therapy Revenue in 2020 Figure 7. By Type - United States Gene Therapy Revenue Market Share, 2016-2027 Figure 8. By Application - United States Gene Therapy Revenue Market Share, 2016-2027 Figure 9. Biogen Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 10. Novartis Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 11. Gilead Sciences Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 12. Sarepta Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 13. Alnylam Pharmaceuticals Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 14. Amgen Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 15. Spark Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 16. Akcea Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 17. bluebird bio Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 18. Sunway Biotech Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 19. SIBIONO Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 20. AnGes Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 21. Orchard Therapeutics Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021) Figure 22. Human Stem Cells Institute Gene Therapy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us